Wave Life Sciences (WVE) Share-based Compensation (2015 - 2026)

Wave Life Sciences (WVE) has 12 years of Share-based Compensation data on file, last reported at $21.0 million in Q2 2026.

• Quarterly Share-based Compensation rose 238.15% year-over-year to $21.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $43.8 million (up 144.58% YoY) and the FY2025 annual result came in at $25.0 million, up 90.04% from the prior year.
• Share-based Compensation grew to $21.0 million in Q2 2026, from $9.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $21.0 million in Q2 2026 to a low of $2.3 million in Q3 2022.
• A 5-year average of $5.3 million and a median of $3.5 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2023 — Share-based Compensation tumbled 70.02% — and 2026, when it soared 238.15%.
• Tracing WVE's Share-based Compensation over 5 years: stood at $2.9 million in 2022, then slipped by 19.09% to $2.4 million in 2023, then jumped by 37.93% to $3.2 million in 2024, then jumped by 126.63% to $7.4 million in 2025, then soared by 184.98% to $21.0 million in 2026.
• The last three Share-based Compensation figures came in at $21.0 million (Q2 2026), $9.1 million (Q1 2026), and $7.4 million (Q4 2025), per Business Quant data.